Oral dosage form design and its influence on dissolution rates for a series of drugs.
D000284:Administration, Oral; D002214:Capsules; D001728:Dicumarol; D004054:Diethylstilbestrol; D004074:Digitoxin; D004304:Dosage Forms; D004339:Drug Compounding; D004997:Ethinyl Estradiol; D005750:Gastric Juice; D006854:Hydrocortisone; D010634:Phenobarbital; D010653:Phenylbutazone; D011441:Propylthiouracil; D012110:Reserpine; D012995:Solubility; D013053:Spectrophotometry; D013411:Sulfadiazine; D013501:Surface-Active Agents; D013607:Tablets; D013997:Time Factors; D014466:Ultraviolet Rays
D002214:Capsules; D004304:Dosage Forms; D013501:Surface-Active Agents; D013607:Tablets; D013411:Sulfadiazine; D004997:Ethinyl Estradiol; D011441:Propylthiouracil; D004054:Diethylstilbestrol; D001728:Dicumarol; D012110:Reserpine; D004074:Digitoxin; D010653:Phenylbutazone; D006854:Hydrocortisone; D010634:Phenobarbital